AVEO Pharmaceuticals Competitors and Similar CompaniesClear all
AVEO Pharmaceuticals's competitors and similar companies include Moleculin Biotech, Plus Therapeutics, Immodulon Therapeutics and Khloris Biosciences.
 AVEO Pharmaceuticals AVEO is a biopharmaceutical company focused on the discovery and development of targeted cancer therapeutics. |  Moleculin Biotech Moleculin Biotech is a pharmaceutical company focused on the development of anti-cancer drug candidates. |  Plus Therapeutics Plus Therapeutics is a pharmaceutical company focused on the development of treatments for patients battling cancer and other life-threatening diseases. |  Immodulon Therapeutics Immodulon Therapeutics is an immuno-oncology company focused on the development of treatments for cancer. |  Khloris Biosciences Khloris Biosciences is a biotechnology company developing the treatment of cardiovascular, oncology, and other diseases. | |
Founding Date | Founding Date 2001 | Founding Date 2006 | Founding Date 1996 | Founding Date N/A | Founding Date 2017 |
Type | Type Public | Type Public | Type Public | Type Private | Type Private |
Tags | |||||
Locations | Locations Boston, US HQ | Locations Houston, US HQ | Locations Austin, US HQ San Antonio, US | Locations Hayes, GB HQ London, GB | Locations Mountain View, US HQ |
Employees | Employees 1912% increase | Employees 176% decrease | Employees 1721% increase | Employees 10 | Employees 1214% decrease |
Valuation ($) | Valuation ($) 515.6 m | Valuation ($) 7.5 m | Valuation ($) 8 m | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) $42.3m (FY, 2021) | Revenue (est.) N/A | Revenue (est.) $5.2m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A |
Net income | Net income ($53.3m) (FY, 2021) | Net income ($33.6m) (FY, 2025) | Net income ($22.4m) (FY, 2025) | Net income N/A | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised $ 224m | Total funding raised $ 491k | Total funding raised $ 71.9m | Total funding raised N/A | Total funding raised $ 5m |
For sources of this data, please see the company profile
View Company Profiles
Moleculin Biotech
HQ
Houston, US
Employees
17↓ 6% decrease
Moleculin Biotech is a pharmaceutical company focused on the development of anti-cancer drug candidates.
View companyPlus Therapeutics
HQ
Austin, US
Employees
17↑ 21% increase
Plus Therapeutics is a pharmaceutical company focused on the development of treatments for patients battling cancer and other life-threatening diseases.
View companyImmodulon Therapeutics
HQ
Hayes, GB
Employees
10
Immodulon Therapeutics is an immuno-oncology company focused on the development of treatments for cancer.
View companyKhloris Biosciences
HQ
Mountain View, US
Employees
12↓ 14% decrease
Khloris Biosciences is a biotechnology company developing the treatment of cardiovascular, oncology, and other diseases.
View company